BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23474649)

  • 1. Pulmonary metabolism of resveratrol: in vitro and in vivo evidence.
    Sharan S; Nagar S
    Drug Metab Dispos; 2013 May; 41(5):1163-9. PubMed ID: 23474649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo-formed versus preformed metabolite kinetics of trans-resveratrol-3-sulfate and trans-resveratrol-3-glucuronide.
    Sharan S; Iwuchukwu OF; Canney DJ; Zimmerman CL; Nagar S
    Drug Metab Dispos; 2012 Oct; 40(10):1993-2001. PubMed ID: 22807110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative toxicokinetics of Trans-resveratrol and its major metabolites in Harlan Sprague Dawley rats and B6C3F1/N mice following oral and intravenous administration.
    Mutlu E; Gibbs ST; South N; Pierfelice J; Burback B; Germolec D; Waidyanatha S
    Toxicol Appl Pharmacol; 2020 May; 394():114962. PubMed ID: 32205187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A simple LC-MS/MS method for the simultaneous quantification of resveratrol and its major phase II metabolites: Assessment of their urinary and biliary excretions in rats.
    Qiu Z; Yu J; Dai Y; Chen X; Huang F; Li N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Mar; 1048():85-93. PubMed ID: 28226267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of resveratrol and its metabolites (resveratrol-3-sulfate, resveratrol-3-glucuronide, and dihydroresveratrol) with serum albumin, cytochrome P450 enzymes, and OATP transporters.
    Poór M; Kaci H; Bodnárová S; Mohos V; Fliszár-Nyúl E; Kunsági-Máté S; Özvegy-Laczka C; Lemli B
    Biomed Pharmacother; 2022 Jul; 151():113136. PubMed ID: 35594715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concentration-dependent effects of resveratrol and metabolites on the redox status of human erythrocytes in single-dose studies.
    Pignitter M; Schueller K; Burkon A; Knorr V; Esefelder L; Doberer D; Wolzt M; Somoza V
    J Nutr Biochem; 2016 Jan; 27():164-70. PubMed ID: 26454510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analytical method development for synthesized conjugated metabolites of trans-resveratrol, and application to pharmacokinetic studies.
    Iwuchukwu OF; Sharan S; Canney DJ; Nagar S
    J Pharm Biomed Anal; 2012 Apr; 63():1-8. PubMed ID: 22342060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfated and Glucuronated trans-Resveratrol Metabolites Regulate Chemokines and Sirtuin-1 Expression in U-937 Macrophages.
    Schueller K; Pignitter M; Somoza V
    J Agric Food Chem; 2015 Jul; 63(29):6535-45. PubMed ID: 26111115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of trans-resveratrol and its metabolites in rat serum using liquid chromatography with high-resolution time of flight mass spectrometry.
    Rousova J; Kusler K; Liyanage D; Leadbetter M; Dongari N; Zhang KK; Novikov A; Sauter ER; Kubátová A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Dec; 1039():35-43. PubMed ID: 27818239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model.
    Marier JF; Vachon P; Gritsas A; Zhang J; Moreau JP; Ducharme MP
    J Pharmacol Exp Ther; 2002 Jul; 302(1):369-73. PubMed ID: 12065739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic glucuronidation of resveratrol: interspecies comparison of enzyme kinetic profiles in human, mouse, rat, and dog.
    Maier-Salamon A; Böhmdorfer M; Thalhammer T; Szekeres T; Jaeger W
    Drug Metab Pharmacokinet; 2011; 26(4):364-73. PubMed ID: 21512262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of free and protein-bound trans-resveratrol metabolites and identification of trans-resveratrol-C/O-conjugated diglucuronides - two novel resveratrol metabolites in human plasma.
    Burkon A; Somoza V
    Mol Nutr Food Res; 2008 May; 52(5):549-57. PubMed ID: 18435437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats.
    Kapetanovic IM; Muzzio M; Huang Z; Thompson TN; McCormick DL
    Cancer Chemother Pharmacol; 2011 Sep; 68(3):593-601. PubMed ID: 21116625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cancer growth by resveratrol is related to its low bioavailability.
    Asensi M; Medina I; Ortega A; Carretero J; Baño MC; Obrador E; Estrela JM
    Free Radic Biol Med; 2002 Aug; 33(3):387-98. PubMed ID: 12126761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol (trans-resveratrol, 3,5,4'-trihydroxy-trans-stilbene) glucuronidation exhibits atypical enzyme kinetics in various protein sources.
    Iwuchukwu OF; Nagar S
    Drug Metab Dispos; 2008 Feb; 36(2):322-30. PubMed ID: 17991766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics, tissue distribution and excretion study of resveratrol and its prodrug 3,5,4'-tri-O-acetylresveratrol in rats.
    Liang L; Liu X; Wang Q; Cheng S; Zhang S; Zhang M
    Phytomedicine; 2013 Apr; 20(6):558-63. PubMed ID: 23351959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic study of trans-resveratrol in adult pigs.
    Azorín-Ortuño M; Yañéz-Gascón MJ; Pallarés FJ; Vallejo F; Larrosa M; García-Conesa MT; Tomás-Barberán F; Espín JC
    J Agric Food Chem; 2010 Oct; 58(20):11165-71. PubMed ID: 20886884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolites and tissue distribution of resveratrol in the pig.
    Azorín-Ortuño M; Yáñez-Gascón MJ; Vallejo F; Pallarés FJ; Larrosa M; Lucas R; Morales JC; Tomás-Barberán FA; García-Conesa MT; Espín JC
    Mol Nutr Food Res; 2011 Aug; 55(8):1154-68. PubMed ID: 21710561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simple LC-MS/MS method facilitated by salting-out assisted liquid-liquid extraction to simultaneously determine trans-resveratrol and its glucuronide and sulfate conjugates in rat plasma and its application to pharmacokinetic assay.
    Qiu Z; Yu J; Dai Y; Yang Y; Lu X; Xu J; Qin Z; Huang F; Li N
    Biomed Chromatogr; 2017 Nov; 31(11):. PubMed ID: 28475242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics, tissue distribution and excretion study of trans-resveratrol-3-O-glucoside and its two metabolites in rats.
    Su M; Dong C; Wan J; Zhou M
    Phytomedicine; 2019 May; 58():152882. PubMed ID: 30901659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.